news 
OpenAI is Trying to Extend Human Life, with Help from Longevity Startup
In a groundbreaking collaboration, OpenAI has teamed up with longevity science startup Retro Biosciences to push the boundaries of human lifespan. According to recent reports, OpenAI has trained a new AI model called GPT-4b micro in partnership with Retro.
The goal of this partnership is ambitious: extending human life by 10 years. To achieve this, OpenAI and Retro are focused on re-engineering proteins, specifically the Yamanaka factors, which have the potential to turn human skin cells into young-seeming stem cells. This breakthrough could potentially enable the creation of replacement cells and organs, opening up new avenues for medical research.
It’s worth noting that the GPT-4b micro model differs from Google’s AlphaFold, a Nobel prize-winning AI system designed to predict the shape of proteins. Instead, OpenAI has developed a custom-built model tailored specifically for biological research, marking a significant milestone in the development of AI-powered biotech innovations.
OpenAI and Retro have announced their plans to release further research on the model and its outputs, which will provide valuable insights into the potential of this technology.
This collaboration is part of OpenAI’s broader efforts to explore the intersection of AI and biology. As the company continues to push the frontiers of human knowledge, it’s clear that extending human lifespan is a critical goal in their research agenda.
We can expect more updates on this project as it develops.
Source: techcrunch.com
